Difference between revisions of "Elafin (TG3)"
m |
m |
||
Line 1: | Line 1: | ||
{| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | {| class="toccolours" border="1" style="float: left; clear: right; margin: 0 0 1em 1em; border-collapse: collapse;" | ||
− | ! | + | ! {infobox header}| '''{{PAGENAME}}''' |
|- | |- | ||
| align="center" colspan="2" bgcolor="#ffffff" | [[Image:Elafin.JPG|200px|{{PAGENAME}}]] | | align="center" colspan="2" bgcolor="#ffffff" | [[Image:Elafin.JPG|200px|{{PAGENAME}}]] | ||
Line 54: | Line 54: | ||
|{{#ev:dailymotion|ot2lRay5hDTBDkXRI|300}} | |{{#ev:dailymotion|ot2lRay5hDTBDkXRI|300}} | ||
|- | |- | ||
− | | | + | | {infobox header} | |
|- | |- | ||
|} | |} | ||
[[Category:Epidermal transglutaminase|*]] | [[Category:Epidermal transglutaminase|*]] |
Latest revision as of 12:03, 10 March 2015
Elafin (TG3) | |
---|---|
Substrate peptide name | Elafin |
Synonyms | Cementoin
Elastase-specific inhibitor |
Determination type | In situ/In vitro |
Source | Homo sapiens |
Subcellular localization | Cornified evelope |
Swissprot ID | P19957 |
Reactive glutamines | Q2 Q59 |
Reactive lysines | K6 |
Substrate sequence | AQEPVKGPV
ACFVPQ |
Structure | 2REL |
Surface accessibility | ASAView pdf
ASAView txt |
Disorder prediction | IUPred |
Reference | PMID:7543090 |
Notes | |
Video | ot2lRay5hDTBDkXRI|300}} |